ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,339,282 | -22.4% | 2,137,577 | -12.1% | 0.00% | 0.0% |
| Q2 2023 | $5,591,005 | +363.0% | 2,430,872 | +509.9% | 0.00% | – |
| Q1 2023 | $1,207,571 | -22.3% | 398,538 | -40.3% | 0.00% | – |
| Q4 2022 | $1,554,250 | +77.8% | 667,060 | +45.7% | 0.00% | – |
| Q3 2022 | $874,000 | -10.7% | 457,959 | +26.8% | 0.00% | – |
| Q2 2022 | $979,000 | -60.3% | 361,253 | -56.3% | 0.00% | – |
| Q1 2022 | $2,464,000 | -33.4% | 826,979 | -13.0% | 0.00% | – |
| Q4 2021 | $3,698,000 | -18.6% | 950,848 | -10.2% | 0.00% | – |
| Q3 2021 | $4,541,000 | +151.9% | 1,058,474 | +77.9% | 0.00% | – |
| Q2 2021 | $1,803,000 | -50.3% | 594,831 | -45.4% | 0.00% | -100.0% |
| Q1 2021 | $3,626,000 | +116.5% | 1,088,843 | +130.6% | 0.00% | – |
| Q4 2020 | $1,675,000 | +122.7% | 472,097 | +96.4% | 0.00% | – |
| Q3 2020 | $752,000 | -70.0% | 240,366 | -82.5% | 0.00% | -100.0% |
| Q2 2020 | $2,505,000 | +0.1% | 1,375,955 | -44.5% | 0.00% | 0.0% |
| Q1 2020 | $2,503,000 | +1267.8% | 2,478,119 | +3660.8% | 0.00% | – |
| Q4 2019 | $183,000 | +632.0% | 65,893 | +451.0% | 0.00% | – |
| Q2 2019 | $25,000 | -51.0% | 11,959 | -15.9% | 0.00% | – |
| Q1 2019 | $51,000 | -19.0% | 14,225 | -13.8% | 0.00% | – |
| Q4 2018 | $63,000 | -89.0% | 16,500 | -79.0% | 0.00% | – |
| Q2 2018 | $574,000 | +77.2% | 78,617 | +21.3% | 0.00% | – |
| Q1 2018 | $324,000 | +121.9% | 64,797 | +124.9% | 0.00% | – |
| Q4 2017 | $146,000 | +180.8% | 28,816 | +99.7% | 0.00% | – |
| Q2 2017 | $52,000 | +52.9% | 14,428 | +37.2% | 0.00% | – |
| Q1 2017 | $34,000 | -81.6% | 10,519 | -86.1% | 0.00% | – |
| Q4 2016 | $185,000 | +374.4% | 75,648 | +563.6% | 0.00% | – |
| Q3 2016 | $39,000 | -96.7% | 11,400 | -95.8% | 0.00% | -100.0% |
| Q4 2015 | $1,198,000 | -73.9% | 269,245 | -64.3% | 0.00% | -75.0% |
| Q3 2015 | $4,596,000 | – | 754,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |